How many insider declarations does Neurizon Therapeutics Limited have?

Neurizon Therapeutics Limited has filed 2 insider declarations with ASX.

Who is the top reporting insider at Neurizon Therapeutics Limited?

The top reporting insider at Neurizon Therapeutics Limited is Dr. Michael Thurn, based on the count of public filings.

What is the net insider buy vs sell volume on Neurizon Therapeutics Limited?

Across the available history, declared buys total 0 and disposals 0.

What is the ISIN of Neurizon Therapeutics Limited?

The ISIN of Neurizon Therapeutics Limited is AU0000357261.

InsidersTradesSigma

← Companies ★ Sign in to follow

Neurizon Therapeutics Limited: management transactions · Australia · ASX

ASX:neurizon-therapeutics-limitedAU0000357261AU·ASXMcap 79M€

AMF ↗

Browse the full directors' dealings record of Neurizon Therapeutics Limited, a listed issuer based in Australia. Shares trade on AU AU, under the supervision of ASX. Market capitalisation: €78.8m. The latest transaction was filed on 12 May 2026 (Other). Among the most active insiders: Dr. Michael Thurn. All data is openly available.

2

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended June 2025 · cache

0.07 €

Income statement

Revenue2.8 M€

Gross profit2.0 M€72% margin

Net income−16.6 M€-587.6% margin

Balance sheet & cash

Market cap78.8 M€

Total debt1.0 M€

Free Cash Flow−14.3 M€

Last declaration on 12 May 2026

All Executives2 Thresholds Prospectus Other

Declarations2 total

Executives●Other11ASX

D

Dr. Michael ThurnDirector

ShareASX

ASX:2924-03089281-6A1325154·12 May 2026

ASX ↗

Executives●Other11ASX

D

Dr Ross Murdoch Date of appointment 8 May 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trustDirector

ShareASX

ASX:2924-03089273-6A1325148·12 May 2026

ASX ↗

2 of 2 declarations